Ruben Mars, PhD

After a PhD in medical microbiology at the University of Groningen, the Netherlands, a postdoc on high throughput metabolomics approaches for the study of the microbiome at ETH Zurich, Switzerland, and a brief stint in industry, Ruben became specialized in human microbiome and metabolome data analysis and interpretation, integrating multi-omics data, and translating these findings into practice. He’s an expert in translational efforts to bring microbiome-based diagnostics and therapies into the clinic. The current focus of his research is translational science related to the gut microbiome in cancer treatment outcomes.

Ruben helped invent some of Tiny Health's first metrics, and he's excited to see the company's growing impact on people's lives.